{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:29:48Z","timestamp":1793820588790,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mathematical Biosciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mbs.2026.109827","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:55:55Z","timestamp":1792022155000},"page":"109827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Parkinson\u2019s disease, Gaucher disease, and bistability in the lysosomal degradation pathway"],"prefix":"10.1016","volume":"402","author":[{"given":"Michael C.","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lansbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Justman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Frederik","family":"Nijhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mbs.2026.109827_bib0001","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12017-010-8132-8","article-title":"An introduction to sphingolipid metabolism and analysis by new technologies","volume":"12","author":"Chen","year":"2010","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.mbs.2026.109827_bib0002","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/cr2002917","article-title":"Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics","volume":"111","author":"Merrill","year":"2011","journal-title":"Chem. Rev."},{"issue":"29","key":"10.1016\/j.mbs.2026.109827_bib0003","article-title":"Sialidosis: a review of morphology and molecular biology of a rare pediatric disorder","volume":"8","author":"Kahn","year":"2018","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.mbs.2026.109827_bib0004","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported","volume":"18","author":"Maegawa","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.mbs.2026.109827_bib0005","article-title":"Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-jewish, caucasian cohort of Gaucher disease patients","volume":"8","author":"Rolpfs","year":"2013","journal-title":"PLOS1"},{"key":"10.1016\/j.mbs.2026.109827_bib0006","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mbs.2026.109827_bib0007","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymgme.2004.11.007","article-title":"Gaucher disease and Parkinsonism","volume":"84","author":"Sidransky","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mbs.2026.109827_bib0008","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.mbs.2026.109827_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson\u2019s disease in type 1\u202fGaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mbs.2026.109827_bib0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with Parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to Parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mbs.2026.109827_bib0011","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1194\/jlr.D010033","article-title":"A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease","volume":"51","author":"Bedia","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mbs.2026.109827_bib0012","doi-asserted-by":"crossref","first-page":"208","DOI":"10.14336\/AD.2017.0505","article-title":"Glucocerebrosidase mRNA is diminished in brain of Lewy body diseases and changes with disease progression in blood","volume":"9","author":"Perez-Roca","year":"2018","journal-title":"Ageing Dis."},{"key":"10.1016\/j.mbs.2026.109827_bib0013","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.177","article-title":"Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease","volume":"2","author":"Rocha","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.mbs.2026.109827_bib0014","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2018.02.028","article-title":"Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain","volume":"67","author":"Hallett","year":"2018","journal-title":"Neurol. Ageing"},{"key":"10.1016\/j.mbs.2026.109827_bib0015","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1016\/S0021-9258(19)39223-3","article-title":"Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis","volume":"265","author":"Grace","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mbs.2026.109827_bib0016","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0021-9258(19)67845-2","article-title":"Characterization of human glucocerebrosidase from different mutant alleles","volume":"266","author":"Ohashi","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mbs.2026.109827_bib0017","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.mbs.2026.109827_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling Parkinson\u2019s disease with the alpha-synuclein protein","volume":"11","author":"Gomez-Benito","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mbs.2026.109827_bib0019","doi-asserted-by":"crossref","unstructured":"J. Kluss, D. Jiang, S. Andrews, R. Ravi, R. Maciuca, B. Tsogtbaatar, C. Tran, M. Fang, E. Macklin, A. Henry, M. Schwartzchild, S. Huntwork-Rodriguez, CSF glucosylsphingosine is a central readout of GCASE impairment across genetic and sporadic Parkinson\u2019s disease, (2026). 10.64898\/2026.0619.733447.","DOI":"10.64898\/2026.06.19.733447"},{"key":"10.1016\/j.mbs.2026.109827_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-synuclein aggregation in Parkinson\u2019s disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.mbs.2026.109827_bib0021","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mbs.2026.109827_bib0022","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.mbs.2026.109827_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson\u2019s disease linked to pathological \u03b1-Synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.mbs.2026.109827_bib0024","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles, and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mbs.2026.109827_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.mbs.2026.109827_bib0026","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"Alpha-synuclein\u2013induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.mbs.2026.109827_bib0027","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson\u2019s disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"issue":"177","key":"10.1016\/j.mbs.2026.109827_bib0028","first-page":"1","article-title":"Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction","volume":"11","author":"Chedid","year":"2025","journal-title":"Parkinson\u2019s Dis."},{"key":"10.1016\/j.mbs.2026.109827_bib0029","series-title":"An Introduction to Systems Biology: Design Principles of Biological Circuits","author":"Alon","year":"2006"},{"key":"10.1016\/j.mbs.2026.109827_bib0030","first-page":"1","article-title":"Systems biology of robustness and homeostatic mechanisms","volume":"11","author":"Nijhout","year":"2018","journal-title":"WIRES Syst. Biol. Med."},{"key":"10.1016\/j.mbs.2026.109827_bib0031","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/oxfordjournals.jbchem.a121991","article-title":"Human placental sialidase: partial purification and characterization","volume":"101","author":"Hiraiwa","year":"1987","journal-title":"J. Biochem."},{"key":"10.1016\/j.mbs.2026.109827_bib0032","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0076-6879(69)14031-8","article-title":"Beta-galactosidase from rat brain","volume":"14","author":"Gatt","year":"1969","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.mbs.2026.109827_bib0033","doi-asserted-by":"crossref","first-page":"30889","DOI":"10.1074\/jbc.M700832200","article-title":"Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase","volume":"282","author":"Hayashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mbs.2026.109827_bib0034","first-page":"63","article-title":"Beta-glucocerebrosidase: mechanistic studies with covalent and non-covalent inhibitors","volume":"150","author":"Legler","year":"1988","journal-title":"NATO ASI Ser. A, Life Sci."},{"key":"10.1016\/j.mbs.2026.109827_bib0035","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/S0021-9258(19)43595-3","article-title":"Isolation and characterization of glucocerebrosidase from human placental tissue","volume":"248","author":"Pentchev","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mbs.2026.109827_bib0036","doi-asserted-by":"crossref","first-page":"29948","DOI":"10.1074\/jbc.M303310200","article-title":"The reverse activity of human acid ceramidase","volume":"278","author":"Okino","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mbs.2026.109827_bib0037","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/abbi.1994.1248","article-title":"Stimulation of acid ceramidase by saposin D","volume":"311","author":"Azuma","year":"1994","journal-title":"Arch. Biocem. BioPhys."},{"key":"10.1016\/j.mbs.2026.109827_bib0038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ng983","article-title":"Variation in gene expression within and among natural populations","volume":"32","author":"Oleksiak","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mbs.2026.109827_bib0039","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1152\/physiolgenomics.00051.2002","article-title":"Individual variation of adipose gene expression and identification of covariated genes by cDNA microarrays","volume":"11","author":"Boeuf","year":"2002","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.mbs.2026.109827_bib0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05316","article-title":"Variability and memory of protein levels in human cells","volume":"444","author":"Sigal","year":"2006","journal-title":"Nat. Lett."},{"key":"10.1016\/j.mbs.2026.109827_bib0041","series-title":"Gaucher Disease","first-page":"1","author":"Brady","year":"2007"},{"key":"10.1016\/j.mbs.2026.109827_bib0042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"The metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. BioPhys. Res. Commun."},{"key":"10.1016\/j.mbs.2026.109827_bib0043","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Deemonstration of a deficiency in glucocerebroside-cleaving enzyme in Gaucher\u2019s disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mbs.2026.109827_bib0044","series-title":"Gaucher Disease","first-page":"155","author":"Mistry","year":"2007"},{"key":"10.1016\/j.mbs.2026.109827_bib0045","series-title":"Gaucher Disease","first-page":"175","author":"Schiffmann","year":"2007"},{"key":"10.1016\/j.mbs.2026.109827_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2022.934820","article-title":"Neuronopathic Gaucher disease: beyond lysosomal dysfunction","volume":"15","author":"Arevalo","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mbs.2026.109827_bib0047","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymgme.2004.11.007","article-title":"Gaucher disease and parkinsonism","volume":"84","author":"Sidranski","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"380-384","key":"10.1016\/j.mbs.2026.109827_bib0048","article-title":"The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson\u2019s disease","volume":"12","author":"Kinghorn","year":"2017","journal-title":"Nuer. Regen. Res."},{"key":"10.1016\/j.mbs.2026.109827_bib0049","first-page":"1","article-title":"Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson\u2019s dieases: insights for drug discovery","volume":"379","author":"Hull","year":"2023","journal-title":"Phil. TRans. Roy. Soc."},{"key":"10.1016\/j.mbs.2026.109827_bib0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mbs.2026.109827_bib0051","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson\u2019s disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.mbs.2026.109827_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2008.01.014","article-title":"Backward bifurcations and multiple equilibria in epidemic models with structured immunity","volume":"252","author":"Reluga","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.mbs.2026.109827_bib0053","first-page":"1","article-title":"Control of tissue homeostasis, tumorigenesis, and degeneration by coupled bidirectional bistable switches","volume":"10","author":"Avila","year":"2021","journal-title":"PLOS Comput. Biol."},{"key":"10.1016\/j.mbs.2026.109827_bib0054","first-page":"624","article-title":"A mathematical model of the pathogenesis, prevention, and reversal of Type 2 diabetes","volume":"28","author":"Ha","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.mbs.2026.109827_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0098756","article-title":"Bistability in glycolysis pathway as a physiological switch in energy metabolism","volume":"9","author":"Mulukutla","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mbs.2026.109827_bib0056","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mbs.2014.08.015","article-title":"Escape from homeostasis","volume":"257","author":"Nijhout","year":"2014","journal-title":"Math. Biosci."},{"key":"10.1016\/j.mbs.2026.109827_bib0057","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/icb\/icu010","article-title":"Homeostasis and dynamic stability of the phenotype link robustness and plasticity","volume":"54","author":"Nijhout","year":"2014","journal-title":"Integr. Comp. Biol."},{"key":"10.1016\/j.mbs.2026.109827_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12915-015-0189-2","article-title":"Using mathematical models to understand metabolism, genes, and disease","volume":"13","author":"Nijhout","year":"2015","journal-title":"BMC Biol."},{"key":"10.1016\/j.mbs.2026.109827_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11538-026-01664-w","article-title":"Cells. bureaucracy, and corruption","volume":"88","author":"Adler","year":"2026","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.mbs.2026.109827_bib0060","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1073\/pnas.0308265100","article-title":"Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems","volume":"101","author":"Angeli","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.mbs.2026.109827_bib0061","series-title":"Biological Clocks, Rhythms, and Oscillations: The Theory of Biological Timekeeping","author":"Forger","year":"2017"},{"key":"10.1016\/j.mbs.2026.109827_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12918-015-0164-0","article-title":"Finding the positive feedback loops underlying multi-stationarity","volume":"9","author":"Feliu","year":"2015","journal-title":"BMC Syst. Biol."}],"container-title":["Mathematical Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556426002178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556426002178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:08:30Z","timestamp":1793819310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025556426002178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":62,"alternative-id":["S0025556426002178"],"URL":"https:\/\/doi.org\/10.1016\/j.mbs.2026.109827","relation":{},"ISSN":["0025-5564"],"issn-type":[{"value":"0025-5564","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson\u2019s disease, Gaucher disease, and bistability in the lysosomal degradation pathway","name":"articletitle","label":"Article Title"},{"value":"Mathematical Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbs.2026.109827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109827"}}